Intuitive Surgical, Inc
Intuitive Surgical designs and sells robotic-assisted surgical systems and related instruments, accessories, software, and services used to perform minimally invasive procedures. Its core platform, da Vinci, is used across soft-tissue surgery, while Ion extends the company into endoluminal diagnostics and broader procedural workflows.
Fiscal year 2025 · change from previous year
Development 2020–2025
Business
Share of revenueCapital equipment platforms for minimally invasive soft-tissue surgery, including da Vinci 5, Xi, X, and SP.
Recurring consumables and procedure-specific tools used with installed da Vinci systems.
Maintenance, customer support, learning, and related services for installed systems and users.
My Intuitive and My Intuitive+ tools that provide performance insights, training, and workflow support.
Ion system and related rollout activities for lung and other diagnostic applications.
Products
Reported · share of revenue- Instrumentsand Accessories59.8 %
- Systems24.6 %
- Services15.6 %
Source: 10-K FY2025, revenue the company reports per product line (SEC XBRL). Shares are of the lines shown and add up to 100 %.
Customers
Customers are hospitals, health systems, ambulatory surgery centers, and physicians that adopt robotic-assisted surgery to improve outcomes, efficiency, and patient experience. The company also serves government customers and, in some markets, uses distributors and joint ventures to reach local providers. Demand is driven by procedure volume, reimbursement dynamics, and the clinical and economic value of minimally invasive surgery.
Buy da Vinci systems, instruments, and service to build or expand robotic surgery programs and attract procedures.
Use the systems and digital tools to improve precision, training, collaboration, and case review.
Adopt smaller or more flexible robotic platforms for selected procedures and throughput-sensitive settings.
Purchase through direct sales or distributors in certain countries where procurement is centralized.
Use Ion for endoluminal diagnostic applications as the company expands beyond surgery.
Strategy
Intuitive is focused on expanding minimally invasive care by improving clinical outcomes, lowering total episode cost, and broadening adoption across procedure types and geographies. The company is investing in next-generation platforms, digital workflow tools, manufacturing capacity, and supply-chain integration to support growth and defend its installed base.
Higher-feature systems and procedure-specific tools support complex cases and reinforce platform differentiation.
OUS procedures are growing faster proportionally and can reduce dependence on the U.S. market.
Analytics, telepresence, and training tools increase customer stickiness and improve utilization.
Ion extends the company into a new clinical workflow and adds a growth avenue beyond surgery.
Vertical integration and automation support quality, availability, and cost as volumes rise.
Geography
The U.S. remains the largest market, accounting for 68% of revenue in Q1 2025, while the company is expanding its OUS footprint through direct sales, distributors, and the China joint venture. Europe, Japan, South Korea, India, Taiwan, Canada, and China are important growth markets, and management expects OUS revenue to become a larger share over time.
Risks
The business depends on continued adoption of robotic-assisted procedures, strong clinical evidence, and favorable reimbursement and hospital economics. It also faces intense competition, regulatory scrutiny, pricing pressure in China and other markets, and execution risk as it scales new products, manufacturing, and digital offerings.
- Competitive pressure in robotic surgeryImpact: HighLikelihood: Medium
Rivals in surgical robotics and alternative procedures can win customers or force lower pricing.
Exposure: da Vinci systems and instruments
- Regulatory and quality complianceImpact: HighLikelihood: Medium
Medical devices face extensive FDA and foreign requirements, and failures can lead to enforcement or recalls.
Exposure: global commercial operations
- China market and policy riskImpact: HighLikelihood: Medium
Pricing pressure and provincial or national healthcare limits could reduce revenue and margins.
Exposure: China joint venture and distributor channels
- Adoption and reimbursement riskImpact: HighLikelihood: Medium
If patients, physicians, or hospitals do not see clear value, procedure growth can slow.
Exposure: soft-tissue robotic surgery
- Cybersecurity and AI-related product riskImpact: MediumLikelihood: Low
Connected devices and analytics tools can create data, performance, and liability exposure.
Exposure: digital portfolio and connected systems
Accounting
Judgemental itemsContracts include systems, accessories, instruments, and services with different performance obligations.
Impact: Affects timing and mix of revenue between upfront and recurring recognition
Lease structures change when and how system revenue is recognized.
Impact: Can shift revenue and margin timing across periods
Procedures and placements are typically stronger in Q4 and weaker in Q1.
Impact: Can distort short-term growth and margin trends
Highly automated manufacturing and product transitions create obsolescence and reserve risk.
Impact: Affects gross profit and cost of sales
Valuation depends on future cash flow assumptions and product lifecycle expectations.
Impact: Can create non-cash charges to operating results
Global operations and complex tax structures require significant judgment.
Impact: Can move the tax provision and net income
Similar listed companies
Publicly listed companies with a comparable business focus.
Inspire Medical Systems, Inc.
INSP · Surgical & Medical Instruments & Apparatus
Inspire Medical Systems develops and commercializes a minimally invasive neurostimulation therapy for obstructive sleep apnea.
iTonic Holdings Ltd
ITOC · Electromedical & Electrotherapeutic Apparatus
iTonic Holdings Ltd is a U.S.-listed healthcare solutions company organized around Beijing Feitian Zhaoye Technology Co., Ltd., its wholly owned operating subsidiary in Beijing, China.
Longduoduo Co Ltd
LDDD · Services-Health Services
Longduoduo Co Ltd is a U.S.-listed company with operating subsidiaries in Inner Mongolia and Beijing that generates revenue from two main activities: direct…
SS Innovations International, Inc.
SSII · Surgical & Medical Instruments & Apparatus
Merit Medical Systems, Inc
MMSI · Surgical & Medical Instruments & Apparatus
Merit Medical Systems designs, manufactures, and markets proprietary medical devices used in interventional, diagnostic, and therapeutic procedures.
Vicarious Surgical Inc.
RBOT · Orthopedic, Prosthetic & Surgical Appliances & Supplies
Last updated: 24/09/2026